Combined Photobiomodulation and Neurofeedback Study Program
Quietmind is offering to conduct single subject (N=1) research-based programs for people with neurodegenerative, neuropsychiatric or neurodevelopmental conditions, to participate in a 1-2 year intensive program of photobiomodulation and neurofeedback training. Subjects who enroll will receive all study related assessments and consultation at no additional cost.
Equipment Fee: $8500 - 13,000 (1 or 2 years) and includes:
This approach allows us to provide participants with the very latest approaches to treatment within a clinical research oriented context, i.e., we maintain close control over the treatment process through collection of critically important data and then modifying the light stimulation and neurofeedback training protocols accordingly. This approach helps Quietmind to further refine the efficacy of this innovative approach to treatment within the rigorous context of applied clinical research.
For more information contact Marvin Berman, PhD, Principal Investigator at [email protected] or 267-481-3987
Equipment Fee: $8500 - 13,000 (1 or 2 years) and includes:
- Neuradiant 1070 Photobiomodulation and home neurofeedback training system,
- Quarterly Quantitative EEG (QEEG) brainmapping and neuropsychological assessment and
- Monthly consultation including neurofeedback data analysis, feedback and therapy protocol modification.
(Equipment will be used exclusively by the study participants and their caregivers for the entire study period.)
This approach allows us to provide participants with the very latest approaches to treatment within a clinical research oriented context, i.e., we maintain close control over the treatment process through collection of critically important data and then modifying the light stimulation and neurofeedback training protocols accordingly. This approach helps Quietmind to further refine the efficacy of this innovative approach to treatment within the rigorous context of applied clinical research.
For more information contact Marvin Berman, PhD, Principal Investigator at [email protected] or 267-481-3987
